Relapsed Refractory Multiple Myeloma (RRMM)Symptoms, Doctors, Treatments, Advances & More
Learn About Relapsed Refractory Multiple Myeloma (RRMM)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Dana-Farber Cancer Institute, Lipper Multiple Myeloma Center
Jacob Laubach is an Oncologist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Laubach is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Laubach is board certified in Hematology, Internal Medicine, and Medical Oncology.
Emory Winship Cancer Institute
Sagar Lonial is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 33 years. Dr. Lonial is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Aplastic Anemia, and Bone Marrow Transplant. Dr. Lonial is board certified in American Board Of Internal Medicine, 2000.
Atrium Health Levine Cancer Institute (Hematology)
Peter Voorhees is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Voorhees is rated as an Elite provider by MediFind in the treatment of Relapsed Refractory Multiple Myeloma (RRMM). He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Voorhees is board certified in American Board Of Internal Medicine, Hematology. Dr. Voorhees is currently accepting new patients.
Summary: This study is researching a drug called REGN17372 used with another drug called linvoseltamab (each individually called study drug or study drugs when combined) in participants with relapsed (when a tumor comes back) or refractory (when a tumor does not respond to treatment) multiple myeloma. This study is the first time REGN17372 will be given to humans. The aim of the study is to understand if R...
Summary: The purpose of this study is to test the safety of in investigational drug called Liposomal curcumin (LipoCurc) and to find the highest dose that can be given without causing very severe side effects. To do this participants are given LipoCurc and are watched very closely to see what side effects they have and to make sure the side effects are not severe. If the side effects are not severe, then n...